Primemd Stock Fundamentals
| PRMD Stock | USD 0.0005 0.00 0.00% |
Fundamental analysis of Primemd allows traders to better anticipate movements in Primemd's stock price by examining its financial health and performance throughout various phases of its business cycle.
Primemd |
Primemd Company Return On Equity Analysis
Primemd's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Primemd Return On Equity | -0.0685 |
Most of Primemd's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Primemd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Primemd has a Return On Equity of -0.0685. This is 99.71% lower than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The return on equity for all United States stocks is 77.9% lower than that of the firm.
Primemd Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Primemd's current stock value. Our valuation model uses many indicators to compare Primemd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Primemd competition to find correlations between indicators driving Primemd's intrinsic value. More Info.Primemd is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Primemd's earnings, one of the primary drivers of an investment's value.Primemd Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Primemd's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Primemd could also be used in its relative valuation, which is a method of valuing Primemd by comparing valuation metrics of similar companies.Primemd is currently under evaluation in return on equity category among its peers.
Primemd Fundamentals
| Return On Equity | -0.0685 | |||
| Return On Asset | -0.0182 | |||
| Profit Margin | (1.17) % | |||
| Operating Margin | (0.58) % | |||
| Current Valuation | 76.82 K | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.47 X | |||
| Revenue | 69.98 K | |||
| Gross Profit | 67.8 K | |||
| EBITDA | (36.75 K) | |||
| Net Income | (101.12 K) | |||
| Cash And Equivalents | 435.5 K | |||
| Cash Per Share | 0.14 X | |||
| Current Ratio | 1.20 X | |||
| Book Value Per Share | 0.38 X | |||
| Cash Flow From Operations | (90.82 K) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | -4.28 | |||
| Market Capitalization | 76.82 K |
About Primemd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Primemd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Primemd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Primemd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Primemd Inc., together with its subsidiaries, is engaged in the purchase and development of residential and commercial real estate properties in the United States. The company was formerly known as Eagle Exploration Co. and changed its name to Primemd Inc. in June 2021. Primemd is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Primemd Pink Sheet
Primemd financial ratios help investors to determine whether Primemd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Primemd with respect to the benefits of owning Primemd security.